Time trends in co-occurring substance use and psychiatric illness (dual diagnosis) from 2000 to 2017 – a nationwide study of Danish register data

References

• Disease GBD, injury I, prevalence C. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1789–1858.
   PubMed Web of Science ®Google Scholar
• Collaborators GBDMD. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet Psychiatry. 2022;9(2):137–150.
   PubMed Web of Science ®Google Scholar
• Jensen HAR, Davidsen M, Ekholm O, et al. The health of the Danes: the national health profile. [Danskernes Sundhed – Den Nationale Sundhedsprofil 2017]. Copenhagen: Sundhedsstyrelsen; 2017.
   Google Scholar
• Sundhedsstyrelsen. Fagligt oplaeg til en 10-årsplan. Bedre mental sundhed og en styrket indsats til mennesker med psykiske lidelser. Danish Board of Health; 2022.
   Google Scholar
• The Danish Board of Health. The prevalence of illicit drug use in the Danish popultion and among young people [Udbredelse af illegale stoffer i befolkningen og blandt de unge]. Denmark: The Danish Board of Health; 2020.
   Google Scholar
• Drake RE, Mueser KT, Clark RE, et al. The course, treatment, and outcome of substance disorder in persons with severe mental illness. Am J Orthopsychiatry. 1996;66(1):42–51.
   PubMed Web of Science ®Google Scholar
• Toftdahl NG, Nordentoft M, Hjorthoj C. Prevalence of substance use disorders in psychiatric patients: a nationwide Danish population-based study. Soc Psychiatry Psychiatr Epidemiol. 2016;51(1):129–140.
   PubMed Web of Science ®Google Scholar
• Petersen SM, Toftdahl NG, Nordentoft M, et al. Schizophrenia is associated with increased risk of subsequent substance abuse diagnosis: a nation-wide population-based register study. Addiction. 2019;114(12):2217–2226.
   PubMed Web of Science ®Google Scholar
• Benjaminsen LJ, Hilm Enemark M, Bastholm Andrade S. Socialt udsatte borgeres brug af velfaerdssystemet. Samfundsøkonomiske aspekter. Det nationale forsknings- og analysecenter for velfaerd. VIVE - Det Nationale Forsknings- og Analysecenter for Velfærd, 2018.
   Google Scholar
• Nesvag R, Knudsen GP, Bakken IJ, et al. Substance use disorders in schizophrenia, bipolar disorder, and depressive illness: a registry-based study. Soc Psychiatry Psychiatr Epidemiol. 2015;50(8):1267–1276.
   PubMed Web of Science ®Google Scholar
• Grant BF, Stinson FS, Dawson DA, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2004;61(8):807–816.
   PubMed Web of Science ®Google Scholar
• Grant BF, Stinson FS, Dawson DA, et al. Co-occurrence of 12-month alcohol and drug use disorders and personality disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2004;61(4):361–368.
   PubMed Web of Science ®Google Scholar
• Hunt GE, Large MM, Cleary M, et al. Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990–2017: systematic review and meta-analysis. Drug Alcohol Depend. 2018;191:234–258.
   PubMed Web of Science ®Google Scholar
• Hjorthoj C, Larsen MO, Starzer MSK, et al. Annual incidence of cannabis-induced psychosis, other substance-induced psychoses and dually diagnosed schizophrenia and cannabis use disorder in Denmark from 1994 to. Psychol Med. 2016;2019:1–6.
   Google Scholar
• Hansen SS, Munk-Jørgensen P, Guldbaek B, et al. Psychoactive substance use diagnoses among psychiatric in-patients. Acta Psychiatr Scand. 2000;102(6):432–438.
   PubMed Web of Science ®Google Scholar
• Bahorik AL, Newhill CE, Queen CC, et al. Under-reporting of drug use among individuals with schizophrenia: prevalence and predictors. Psychol Med. 2014;44(1):61–69.
   PubMed Web of Science ®Google Scholar
• Jorgensen KB, Nordentoft M, Hjorthoj C. Association between alcohol and substance use disorders and psychiatric service use in patients with severe mental illness: a nationwide Danish register-based cohort study. Psychol Med. 2018;48(15):2592–2600.
   PubMed Web of Science ®Google Scholar
• Ness O, Borg M, Davidson L. Facilitators and barriers in dual recovery: a literature review of first-person perspectives. Advances in Dual Diagnosis. 2014;7(3):107–117.
   Google Scholar
• Torrens MPJA, Domingo-Salvany A. Comorbidity of substance use and mental disorders in Europe. European monitoring Centre for drugs and drug addiction. 2015. https://www.emcdda.europa.eu/system/files/publications/1988/TDXD15019ENN.pdf
   Google Scholar
• Hjorthoj C, Ostergaard ML, Benros ME, et al. Association between alcohol and substance use disorders and all-cause and cause-specific mortality in schizophrenia, bipolar disorder, and unipolar depression: a nationwide, prospective, register-based study. Lancet Psychiatry. 2015;2(9):801–808.
   PubMed Web of Science ®Google Scholar
• Batki SL, Meszaros ZS, Strutynski K, et al. Medical comorbidity in patients with schizophrenia and alcohol dependence. Schizophr Res. 2009;107(2–3):139–146.
   PubMed Web of Science ®Google Scholar
• Benaiges I, Prat G, Adan A. Health-related quality of life in patients with dual diagnosis: clinical correlates. Health Qual Life Outcomes. 2012;10:106.
   PubMed Web of Science ®Google Scholar
• Health Mo. Healthcare in Denmark - an overview. Copenhagen, Denmark: Health Mo; 2017.
   Google Scholar
• Schmidt M, Schmidt SA, Sandegaard JL, et al. The Danish national patient registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490.
   PubMed Web of Science ®Google Scholar
• Lynge E, Sandegaard JL, Rebolj M. The Danish national patient register. Scand J Public Health. 2011;39(7):30–33.
   PubMed Web of Science ®Google Scholar
• Kildemoes HW, Sorensen HT, Hallas J. The Danish national prescription registry. Scand J Public Health. 2011;39(7):38–41.
   PubMedGoogle Scholar
• Addiction EMCfDaD. European drug report 2022: Trends and developments. Luxembourg: Publications Office of the European Union; 2022.
   Google Scholar
• Stralin P, Hetta J. Substance use disorders before, at and after first episode psychosis hospitalizations in a young national Swedish cohort. Drug Alcohol Depend. 2020;209:107919.
   PubMed Web of Science ®Google Scholar
• Hjorthoj C, Posselt CM, Nordentoft M. Development over time of the population-attributable risk fraction for cannabis use disorder in schizophrenia in Denmark. JAMA Psychiatry. 2021;78(9):1013.
   PubMed Web of Science ®Google Scholar
• Manthey J, Freeman TP, Kilian C, et al. Public health monitoring of cannabis use in Europe: prevalence of use, cannabis potency, and treatment rates. Lancet Reg Health Eur. 2021;10:100227.
   PubMedGoogle Scholar
• Martensson S, Johansen KS, Hesse M, et al. Changes in co-occurring substance diagnosis among patients admitted to psychiatric treatment over a twenty-year period. Acta Psychiatr Scand. 2022;145(2):226–228.
   PubMed Web of Science ®Google Scholar
• Als Research & Kompetencecenter for Dobbeltdiagnoser. Slutrapport: Projekt 65301, delprojekt 1: Styrket Indsats for Dobbeltdiagnosticerede Voksne. Roskilde: Kompetencecenter for Dobbeltdiagnoser. 2017.
   Google Scholar
• Johansen KS, Thylstrup B. Hvad har vi lært af 15 års projekter på dobbeltdiagnoseområdet? Kompetencecenter for Dobbeltdiagnoser, Region Hovedstadens Psykiatri og Center for Rusmiddelforskning, Aarhus Universitet. 2022.
   Google Scholar
• Jeppesen RM, Christensen T, Vestergaard CH. Changes in the utilization of psychiatric hospital facilities in Denmark by patients diagnosed with schizophrenia from 1970 through 2012: the advent of 'revolving door’ patients. Acta Psychiatr Scand. 2016;133(5):419–425.
   PubMed Web of Science ®Google Scholar
• Rogeberg O, Pedersen W. Help-seeking behaviour among illegal substance users. Tidsskr Nor Laegeforen. 2021;141(9).
   PubMed Web of Science ®Google Scholar